Inventor · disambiguated record
Phillip R. Morrow
Also filed as: MORROW LEGAL REPRESENTATIVE JEANNE · MORROW PHILLIP R · SCHOLZ WOLFGANG
4 granted patents·5 pending applications·299 citations·filing 1996–2008
83Inventor score
Files withEMERGENT PRODUCT DEV GAITHERSB3MORROW PHILLIP R2BIOGEN IDEC INC1IDEC PHARMA CORP1XENEREX BIOSCIENCES1
Top patents by PatentIndex Score
9 records- 0196US5958765ANeutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereofIDEC PHARMA CORP·Filed 1996·Granted Sep 28, 1999·185 cites·28 claims
- 0295US7442373B2Antibodies against protective antigen and methods of use for passive immunization and treatment of anthraxEMERGENT PRODUCT DEV GAITHERSB·Filed 2005·Granted Oct 28, 2008·31 cites·21 claims
- 0393US6537809B2Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereofXENEREX BIOSCIENCES·Filed 2000·Granted Mar 25, 2003·74 cites·29 claims
- 0491US7438909B2Immunization and treatment methods for anthraxEMERGENT PRODUCT DEV GAITHERSB·Filed 2005·Granted Oct 21, 2008·9 cites·14 claims
- 0564US2009202553A1Antibodies against anthrax protective antigenEMERGENT PRODUCT DEV GAITHERSB·Filed 2008·Application pending·0 cites
- 0662US2007082002A1Neutralizing High Affinity Human Monoclonal Antibodies Specific to RSV F-Protein and Methods for their Manufacture and Therapeutic use thereofBIOGEN IDEC INC·Filed 2006·Application pending·0 cites
- 0758US2006246079A1Neutralizing human antibodies to anthrax toxinMORROW PHILLIP R·Filed 2005·Application pending·0 cites
- 0855US2004076631A1Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereofFiled 2002·Application pending·0 cites
- 0938US2005281830A1Detection, prevention, and treatment systems for anthraxMORROW PHILLIP R·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Phillip R. Morrow files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →